In this episode of "We Fixed It. You're Welcome," the hosts tackle the challenges facing Weight Watchers (WW) as it navigates a changing landscape of weight loss and wellness.

They discuss WW's $1.6 billion debt, its pivot to telehealth and GLP-1 medications, and potential strategies for revitalization. The conversation explores bundling services, rebranding, and leveraging WW's long-standing reputation to become a leader in post-injectable weight management.

The hosts propose solutions ranging from embracing semi-glutide drugs to decentralizing the brand and acquiring complementary companies. They emphasize the need for quick adaptation to market trends and the importance of maintaining community support while modernizing WW's approach to sustainable health.

A quick disclaimer. We are going into this somewhat cold and nothing we say should be construed as legal advice, financial advice or anything that would get us in trouble. These are our views and opinions. We're here to ask the kinds of questions everyone's thinking. Have an engaging conversation and maybe come to some conclusions that we feel are worth exploring.

By the end, if we fixed it, you're welcome. All trademarks, IP and brand elements discussed are property of their respective owners.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.